Early administration of tocilizumab (Toci) for the prevention of grade 4 cytokine release syndrome (CRS) after CD19-directed CAR T-cell therapy (CTL019)
Kadauke, S, Maude, S, Gladney, W, Motley, L, Shenoy, V, Callahan, C, Baniewicz, D, Teachey, D.T, Grupp, S, DiNofia, A
Published in Cytotherapy (Oxford, England) (01.05.2019)
Published in Cytotherapy (Oxford, England) (01.05.2019)
Get full text
Journal Article